Backed by $700M, startup led by vets of Genentech, UCSF, Juno has ambitious cell and gene therapy goals

The 200-employee company has tapped many people from the former Juno Therapeutics and has plans to expand its manufacturing, platforms and workforce.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.